Yarrow Bioscience Inc (YARW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

$78.97M

MomentumView details →

1D Return

+2.53%

YTD Return

+6.17%

RSI (14)

37.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

Market Cap

$78.97M

RSI (14)

37.6

MomentumView details →

1D Return

+2.53%

YTD Return

+6.17%

ProfitabilityView details →

Gross Margin

97.51%

Net Margin

−3881.54%

EBITDA Margin

−3909.96%

ROE (TTM)

−84.80%

ROA (TTM)

−79.26%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+6.12%

EPS CAGR 3Y

+33.80%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$2.14

EPS Surprise

80.55%

Beats (12Q)

1/12

Next Q EPS Est

−$16.00

Avg Surprise (4Q)

80.55%

Rev Surprise

−51.50%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

15.26x

Quick Ratio

15.26x

Div Yield

0.03%

Div Rate

$0.01

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

482000.00

Net Income (TTM)

−18.71M

Op. CF (TTM)

−16.93M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for YARW.

Similar companies

Gain Therapeutics, Inc.GANX Apollomics, Inc.APLM Telomir Pharmaceuticals, Inc. Common StockTELO Dogwood Therapeutics, Inc.DWTX MediciNova, Inc.MNOV OKYO Pharma LimitedOKYO Find similar companies →

Latest newsMore news →

No recent news for YARW.